Request Sample

Global Head and Neck Cancer Market

March 3, 2018

Global Head and Neck Cancer Market, By Cancer Type (Laryngeal Cancer, Lip, and Oral Cavity Cancer, Pharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, and Others), By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) 

Report Code : FMR330      
Pages : 199 Pages
Format :   PPT Format   PDF Format

The global head and neck cancer market was valued at US$ xx million in 2019. This market is estimated to be valued at US$ xx million in the year 2020, and it is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020−2025). Head & neck cancers comprise a number of different malignant tumors that progress in or around the throat, nose, larynx, sinuses, salivary glands, lips, and mouth. There are different types of drugs used alone or in combination to treat the head & neck cancer. Although traditional chemotherapeutic drugs are preferably used in combination of radiation therapy, targeted immune therapies are developing as a standard treatment option for advanced-stage head & neck cancers.   

Table 1. Global Head and Neck Cancer Market Synopsis

   

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Cancer Type)

Laryngeal cancer, lip and oral cavity cancer, pharyngeal cancer, salivary gland cancer, nasopharyngeal cancer, and others.

Market Segmentation (By Treatment Type)

Chemotherapy, Targeted Therapy, Radiation Therapy, and Others

Market Segmentation (By End User)

Hospitals, Specialty Clinics, and Ambulatory Surgical Centers

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa

Key Players Coverage

AB Science SA, Acceleron Pharma, Inc., AbbVie Inc., AdDent Inc., Astellas Pharma Inc., ASAHI Roentgen, AstraZeneca Plc., Boston Biomedical, Inc., Bayer AG, Bristol-Myers Squibb Company, Fujifilm Holdings, Carestream, GE Healthcare, Koninklijke Philips N.V., Identafi, NeuSoft, Siemens Healthcare, Shimadzu Corporation, Varian Medical Systems, and Xoran, among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Growing prevalence of head & neck cancer across the world, increasing demand for combination therapy for management of head & neck cancer, and growth in number of R&D activities to develop ideal therapeutics are expected to fuel the growth of the global head & neck cancer drugs market. Moreover, strong presence of pipeline drugs such as Ipilimumab, Avelumab, Bevacizumab, Durvalumab, Atezolizumab, Erlotinib, Afatinib, and others and technological developments in screening procedure for cancer are expected to drive the market growth. Additionally, upsurge in number of risk factors such as growth in number of alcohol & tobacco consumption and cigarette smoking is further expected to boost the growth of the global head & neck cancer drugs market.

In 2016, Union for International Cancer Control (UICC) estimated that around 550,000 people are diagnosed with head and neck cancer and 300,000 deaths are recorded every year globally. Also, they mentioned that, head and neck cancer are the sixth most common cancer accounting for about 5.0% of all cancers worldwide.

For instance, in June, 2019, Merck & Co., Inc., declared the U.S. Food and Drug Administration (U.S. FDA) agreement for pembrolizumab for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Also, in February 2020, Galera Therapeutics, Inc., announced that Avasopasem manganese (GC4419), a novel drug molecule is in their pipeline for reducing Severe Oral Mucositis (SOD), which is normally induced due to radiotherapy. Such product approvals and pipeline products are expected to result in significant market growth.

Figure 1. Head and Neck Cancer Market Scenario Forecast (Likely, Conservative, and Optimistic Scenario), 2019 and 2025 (US$ Mn)

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is leading the market for head neck cancer. This can be attributed to presence of a large patient pool, stable economy of people, which encourages them to adopt new therapeutics for head and neck cancer. Also, presence of key market players investing in R&D to develop with new therapy options are also fostering the market growth in this region.

Asia-Pacific offers lucrative growth opportunities for key players functioning in the head & neck cancer drugs market due to huge population base, high incidence of head & neck cancer, and increase in demand for head & neck cancer combination therapeutics. Furthermore, rise in cigarette smoking, alcohol consumption, and higher usage of tobacco population are further anticipated to boost the market growth. The most common form of tobacco chewing is betel quid chewing in the Asia-Pacific region. India and China are developing as an opportunity for market expansion. Factors such as beneficial healthcare reforms, growing adaption of biosimilars, and low-cost base are major boosting factors for market expansion in these countries.

Figure 2. Regional Analysis

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Major players in the global head neck cancer market include: Neusoft, AB Science SA, Acceleron Pharma, Inc., AbbVie Inc, AdDent Inc., Astellas Pharma Inc., Shimadzu Corporation, AstraZeneca Plc., ASAHI Roentgen, Boston Biomedical, Inc., Bayer AG, Fujifilm Holdings, Carestream, Bristol-Myers Squibb Company, GE Healthcare, Koninklijke Philips N.V., Identafi, Siemens Healthcare, Varian Medical Systems, and Xoran, among others.

Companies implement strategic initiatives such as mergers, acquisitions, and product launches to maintain their market position. For instance, In October 2018, the U.S. FDA approved the Taxotere, a supplemental new drug, which is in the form of injection concentrate developed by Sanofi S.A. It is injected in mixture with fluorouracil and cisplatin for the treatment of patient’s dealing with inoperable locally advanced head and neck squamous cell carcinoma. Furthermore, in April 2019, NEC Corporation, a multinational provider of information technology products and services, provided a funding of US$ 50 Mn for the transformation of cancer treatments leveraging Precision Medicine Analytics to BostonGene, a biomedical software startup.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Cancer Type

  • Laryngeal Cancer
  • Lip and Oral Cavity Cancer
  • Pharyngeal Cancer
  • Salivary Gland Cancer
  • Nasopharyngeal Cancer
  • Others.

By Treatment Type

  • Chemotherapy
  • Targeted Therapy
  • Radiation Therapy
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global head neck cancer market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global head neck cancer market?
  • What key factors are expected to increase the demand for head neck cancer market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global head neck cancer market?
  • What is the total market value (US$ Mn) generated in the global head neck cancer market by cancer type in 2019, and what are the forecasts by 2025?
  • Which treatment type contributes highest CAGR (%) in the head neck cancer market?
  • Which end user of head neck cancer is expected to propel the market in the foreseen future?
  • What was the total revenue generated by the global head neck cancer market across different regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global head neck cancer market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the global head neck cancer market?
  • What are the new products which are going to be approved or launched in the upcoming years, which may have a huge impact on the market?
  • What insights are derived through the analysis of key players on the following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?
Latest Reports

Global Oncology Precision Medicine Market

Global Oncology Precision Medicine Market, By Ecosystem (Applied Sciences (Genomics, Pharmacogenomics and Other Applied Sciences), Precision Diagnostics (Molecular Diagnostics …

Read More

Global Small Molecule Drug Discovery Market

Global Small Molecule Drug Discovery Market, By Therapeutic Type (Central Nervous System (CNS), Cardiovascular, Oncology, Metabolic Disorders, Gastrointestinal, Orthopedics, …

Read More

Global Diabetes Drugs Market

Global Diabetes Drugs Market, By Diabetes Type (Type-1 & Type-2), By Drug (Oral Anti-Diabetic Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine …

Read More

Global Bipolar Disorder Treatment Market

Global Bipolar Disorder Treatment Market, By Drug Type (Antipsychotic, Antidepressant, Anticonvulsants, Antianxiety, Mood Stabilizers, Others), By Bipolar Disorder Type …

Read More

Global Cytotoxic Drugs Contract Manufacturing Market

Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type (Oral, Intravenous), By Form (Liquid, Solid), By Production Scale (Laboratory …

Read More

India Acetazolamide Market

India Acetazolamide Market, By Formulation (Tablets, Capsules, and Injection), By Application (Glaucoma, Epilepsy, Drug-induced Edema, Altitude …

Read More

India Diclofenac Market

India Diclofenac Market, By Indication (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid Arthritis, Migraine, Pain, and Others), By Route of Administration …

Read More

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market, By Drug Class (Contraceptives & Antiandrogens (Provera, Yasminell, Clomid, Aldactone, Diane 35, …

Read More
Validation error occured. Please enter the fields and submit it again.